Article info
Clinical science
Characteristics of patients with neovascular age-related macular degeneration who are non-responders to intravitreal aflibercept
- Correspondence to Dr Chikako Hara, Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan; chikako.ueno{at}ophthal.med.osaka-u.ac.jp
Citation
Characteristics of patients with neovascular age-related macular degeneration who are non-responders to intravitreal aflibercept
Publication history
- Received March 20, 2018
- Revised May 15, 2018
- Accepted May 28, 2018
- First published June 15, 2018.
Online issue publication
April 17, 2019
Article Versions
- Previous version (15 June 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.